Clinical Trial

Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a single-arm, single-center, exploratory study, the purpose of this study is to evaluate the efficacy and safety of envafolimab combined with Chemoradiotherapy in participants with locally advanced cervical cancer.
Trial Details
NCT Number NCT05799469
Lead Sponsor Chongqing University Cancer Hospital
Conditions Locally Advanced Cervical Cancer
Enrollment 36 participants
Start Date 2023-05-01
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-04-05